Gili Cohen
Vorsitzender bei FLYING SPARK LTD.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Ygal Dimri | M | 67 | 35 Jahre | |
| Eran Gronich | M | 50 | 9 Jahre | |
| Yaacov Elinav | M | 79 | 8 Jahre | |
| Amir Cohen | M | 47 | 22 Jahre | |
| Rachel Hirsh Caduri | F | 49 | 2 Jahre | |
| Bari Bar Zion | M | 59 | 5 Jahre | |
| Tamar Salemnick | F | 68 | 4 Jahre | |
| Ron Striechman | M | 59 | 13 Jahre | |
| Avital Stien | M | 63 | 4 Jahre | |
| Tal Mish Vered | F | 56 | 3 Jahre | |
| Avital Bar Dayan | F | 56 | 3 Jahre | |
| Michael Bar-Haim | M | 69 | 5 Jahre | |
| Yanir Farber | M | 62 | 18 Jahre | |
| Eli Ben-Hamoo | M | 71 | 17 Jahre | |
| Shmuel Slavin | M | 70 | 17 Jahre | |
| Lior Vilenski | F | 37 | 2 Jahre | |
| Aviv Sages | M | 50 | 21 Jahre | |
| Gadi Alikam | M | 65 | 14 Jahre | |
| Dov Baharav | M | 74 |
The College of Management Academic Studies
| - |
| Amir Feffer | M | 52 | 10 Jahre | |
| Hezi Dimri | M | 42 | 20 Jahre | |
| Dalia Narkys | F | 71 |
The College of Management Academic Studies
| - |
| Arnon Zuaretz | M | 70 |
The College of Management Academic Studies
| - |
| Arik Kaufman | M | 42 | 6 Jahre | |
| Balashnikov Avraham | M | 58 |
The College of Management Academic Studies
| - |
| Doron Sela | M | 60 |
The College of Management Academic Studies
| - |
| Erez Yizhak Rozenbuch | M | 52 | - | |
| Ron Hadassi | M | 59 |
The College of Management Academic Studies
| - |
| Osnat Ronen | F | 61 |
The College of Management Academic Studies
| - |
| Shlomo Churi | M | 56 | 29 Jahre | |
| Zohar Segal | M | 47 | 7 Jahre | |
| Shlomo Sonant | M | 66 | 6 Jahre | |
| Tamar Gottlieb | F | 67 |
The College of Management Academic Studies
| - |
| Tali Yaron Dalah | F | 46 | 3 Jahre | |
| Amnon Merhav | M | 58 |
The College of Management Academic Studies
| - |
| Gil Grslr | M | - |
The College of Management Academic Studies
| - |
| Michael Gette | M | 37 | 2 Jahre | |
| Marina Giladov | F | - | 2 Jahre | |
| Lee Ben Yosef | F | - | 3 Jahre | |
| Adi Massael | F | - | - | |
| Shuky Abramowitz | M | 63 |
The College of Management Academic Studies
| - |
| Adi Namer | F | 39 | 11 Jahre | |
| Iris Dimri | F | 61 | 33 Jahre | |
| Elchanan Simcha Harel | M | 75 |
The College of Management Academic Studies
| - |
| Yona Fogel | M | 70 |
The College of Management Academic Studies
| - |
| Nir Zichlinskey | M | 58 |
The College of Management Academic Studies
| - |
| Shalom-Yosef Hochman | M | 77 |
The College of Management Academic Studies
| 14 Jahre |
| Avi Klainer | M | 52 |
The College of Management Academic Studies
| 25 Jahre |
| Nurit Twito | F | 60 | 30 Jahre | |
| Gad Arbel | M | 75 |
The College of Management Academic Studies
| - |
| Shemi Haguel | M | 73 | 16 Jahre | |
| Dror Yehuda | M | 55 | 17 Jahre | |
| Liat Barda Pasha | F | 45 | 2 Jahre | |
| Noga Kainan | F | 69 |
The College of Management Academic Studies
| - |
| Meir Baron | M | - | - | |
| Matzliah Partuk | M | 69 | 20 Jahre | |
| Lior Gotliv | M | - | - | |
| Alla Felder | F | 50 |
The College of Management Academic Studies
| 21 Jahre |
| Aviad Armoni | M | 64 |
The College of Management Academic Studies
| 7 Jahre |
| Hadas Gelander | M | 58 |
The College of Management Academic Studies
| 13 Jahre |
| Bari Ben-Zeev | M | 72 |
The College of Management Academic Studies
| - |
| Oren Gil Or | M | 53 |
The College of Management Academic Studies
| 29 Jahre |
| Yoel Yogev | M | 71 | 7 Jahre | |
| Zaidman Yakov Amir | M | 55 | 8 Jahre | |
| Avraham Basher | M | 67 |
The College of Management Academic Studies
| - |
| Assi Horev | M | 71 | 20 Jahre | |
| Dina Saban | F | 54 | 13 Jahre | |
| David Gerbi | M | 44 |
The College of Management Academic Studies
| - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Yifat Fogel | F | 48 |
Phoenix Investments House Ltd.
 Phoenix Investments House Ltd. Investment ManagersFinance Phoenix Investments House Ltd. is an asset management and holding firm headquartered in Petach Tikva, Israel. The firm was founded by Roni Biram and Gil Deutsch in 1992 as Excellence Investments Ltd. Phoenix Investments House offers a wide range of investment and savings products in the capital market in Israel.
The College of Management Academic Studies
| 11 Jahre |
| Colin Foster | M | 61 |
Bioblast Pharma Ltd.
 Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | 2 Jahre |
| Aryeh Stern | M | - |
The College of Management Academic Studies
| 5 Jahre |
| Udi Gilboa | M | 57 |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | 5 Jahre |
| Michael Burshtine | M | 60 |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | 4 Jahre |
| Yuval Benishti | M | 47 |
The College of Management Academic Studies
| 7 Jahre |
| Dana Harel Harel | F | - |
The College of Management Academic Studies
| 4 Jahre |
| Matan Rabizadeh | M | - |
The College of Management Academic Studies
| 3 Jahre |
| Viktoria Tzadka | F | 44 |
The College of Management Academic Studies
| 7 Jahre |
| Gal Landau-Yaari | F | - |
The College of Management Academic Studies
| 7 Jahre |
| Yonatan de Jongh | M | 43 |
The College of Management Academic Studies
| 6 Jahre |
| Yuval Bernshtein | M | 44 |
The College of Management Academic Studies
| 6 Jahre |
| Eyal Abergel | M | 38 |
The College of Management Academic Studies
| 6 Jahre |
| Amihay Hadad | M | 46 |
The College of Management Academic Studies
| 6 Jahre |
| Robert Friedman | M | 68 |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | 2 Jahre |
| Liami Adas Vaisman | M | 48 |
The College of Management Academic Studies
| 6 Jahre |
| Yaniv Rog | M | 49 |
The College of Management Academic Studies
| 4 Jahre |
| Thomas Dubin | M | 62 |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | 3 Jahre |
| Kles Or | M | 41 |
The College of Management Academic Studies
| 7 Jahre |
| Itzhak Nechushtan | M | 67 | 9 Jahre | |
| Rinat Gazit | F | 54 |
Phoenix Investments House Ltd.
Phoenix Investments House Ltd. Investment ManagersFinance Phoenix Investments House Ltd. is an asset management and holding firm headquartered in Petach Tikva, Israel. The firm was founded by Roni Biram and Gil Deutsch in 1992 as Excellence Investments Ltd. Phoenix Investments House offers a wide range of investment and savings products in the capital market in Israel. | - |
| Yair Levi | M | 43 |
The College of Management Academic Studies
| 4 Jahre |
| Yafit Keret | F | 51 |
The College of Management Academic Studies
| 8 Jahre |
| Isaac Krymolowski | M | 61 |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | - |
| Eyal Boganim | M | 44 |
The College of Management Academic Studies
| 11 Jahre |
| Adi Blumenfeld Pinchas | F | 48 |
The College of Management Academic Studies
| 7 Jahre |
| Ori Mordechai Stern | M | 46 |
The College of Management Academic Studies
| 7 Jahre |
| Lian Goldstein | F | 49 |
The College of Management Academic Studies
| 8 Jahre |
| Chaime Orlev | M | 53 |
Bioblast Pharma Ltd.
Bioblast Pharma Ltd. BiotechnologyHealth Technology Bioblast Pharma Ltd. operates as a clinical development-stage biopharmaceutical company. It focuses on the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic diseases. The company also focuses on diseases with severe and debilitating manifestations, where the unmet medical need is clear, the biological mechanism of action is understood, and for which there is no satisfactory treatment. Its product candidates include Protein Stabilizing, Read-through, and Mitochondrial Protein Replacement Platforms. The company was founded by Dalia Megiddo and Ehud Moshe Gilboa on January 22, 2012 and is headquartered in Tel Aviv, Israel. | 1 Jahre |
| Alex Shmulovich | M | - |
The College of Management Academic Studies
| 5 Jahre |
| Liran Jacobsberg | M | 46 |
The College of Management Academic Studies
| 2 Jahre |
| Alexander Lyahovetski Lavie | M | 35 |
The College of Management Academic Studies
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Israel | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Gili Cohen
- Persönliches Netzwerk
